Full-Time

Global Clinical Lead

Renal Cancer Therapeutics

Confirmed live in the last 24 hours

Telix Pharmaceuticals

Telix Pharmaceuticals

501-1,000 employees

Develops targeted radiation therapies for cancer

Biotechnology
Healthcare

Senior

Remote in USA

Remote position specifically for candidates based in the USA.

Category
Physicians & Surgeons
Medical, Clinical & Veterinary

You match the following Telix Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Medical degree or PhD required
  • Clinical experience in medical oncology required; Nuclear medicine or renal cancer experience is highly preferred
  • 5+ years of experience in clinical development required
  • Strong knowledge of clinical trial design, methodology, and regulatory requirements
  • Successful leadership and project management of clinical development programs
Responsibilities
  • Lead development of clinical development plans for therapeutic assets in renal cancer
  • Collaborate with global program heads, regulatory affairs, medical affairs, and translational medicine teams to ensure alignment of clinical trial objectives with overall asset strategy
  • Develop clinical study plans from concept to synopsis to full protocol, ensuring alignment with the Company’s objectives, and the needs of regulatory authorities, healthcare professionals, patient groups, guidelines committees and payors
  • Develop – in collaboration with relevant cross-functional teams and medical writers – clinical study documentation including, but not limited to informed consent documents, imaging charters, study manuals and final regulatory dossiers.
  • Lead clinical scientific input into documentation including investigator brochures, IMPDs, safety reports (e.g. DSURs, PSURs, and SUSARs), clinical study reports and regulatory documents such as briefing packages, INDs, BLAs, NDAs and MAAs
  • Lead the analysis, review, and quality control of clinical data (e.g. study-related, aggregated) including efficacy, safety, and imaging data to ensure accuracy and quality
  • Prepare and deliver presentations, proposals, and reports for senior management, partners, and other stakeholders
Desired Qualifications
  • Experience with regulatory submissions (e.g., IND, CTA) and interaction with regulatory agencies (e.g., FDA, EMA) is preferred
  • Willingness to travel domestically and internationally, as needed
  • Strong understanding of uro-oncology
Telix Pharmaceuticals

Telix Pharmaceuticals

View

Telix Pharmaceuticals develops and sells biopharmaceutical products aimed at improving the diagnosis and treatment of cancer and rare diseases. The company focuses on creating therapeutic and diagnostic solutions that use targeted radiation, which helps healthcare providers make better treatment decisions and offers personalized therapy for patients with significant medical needs. Their product pipeline includes treatments for prostate and kidney cancers, glioma, sarcoma, and bone marrow conditioning. Telix operates a global supply chain to manufacture and distribute its products, generating revenue through sales to healthcare institutions. The company emphasizes sustainability, patient care, and ethical practices, aiming to create value for patients, shareholders, and employees.

Company Stage

IPO

Total Funding

$14.8M

Headquarters

Melbourne, Australia

Founded

2015

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of ImaginAb's assets allows exploration of new therapeutic areas beyond current focus.
  • Illuccix® approval in Europe opens significant commercial opportunities in the European Economic Area.
  • Strategic partnership with Curium Pharma strengthens supply chain and commercial capabilities.

What critics are saying

  • Increased competition in radiopharmaceuticals may impact Telix's market share.
  • Potential delays in Illuccix®'s European launch due to complex regulatory requirements.
  • Integration challenges from ImaginAb acquisition could disrupt innovation and product development.

What makes Telix Pharmaceuticals unique

  • Telix focuses on molecularly-targeted radiation therapy for prostate, renal, and glioblastoma cancers.
  • The company integrates advanced biologics technology for improved targeting and therapeutic efficacy.
  • Telix's in-house commercialization strategy enhances market distribution and indication expansion.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Annual Performance Bonus

Equity-Based Incentive Program

Paid Vacation

Paid Wellness Days

Hybrid Work Options

Remote Work Options